These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3008524)

  • 21. Marek's disease in chickens: correlation of Marek's disease with nuclear-inclusion formation in feather-follicle epithelium.
    Moriguchi R; Izawa H
    Avian Dis; 1979; 23(3):547-54. PubMed ID: 230801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
    Islam T; Renz KG; Walkden-Brown SW; Ralapanawe S
    Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a quantitative-competitive polymerase chain reaction assay for serotype 1 Marek's disease virus.
    Reddy SM; Witter RL; Gimeno I
    Avian Dis; 2000; 44(4):770-5. PubMed ID: 11195630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multiplication, interference, and interferon induction of avian herpesviruses. Contribution to the vaccination against Marek's disease. 2. Materials and methods, results, discussion and conclusion].
    Kaleta EF
    Zentralbl Veterinarmed B; 1977 Jun; 24(6):429-75. PubMed ID: 196461
    [No Abstract]   [Full Text] [Related]  

  • 25. Biocharacteristics shared by highly protective vaccines against Marek's disease.
    Gimeno IM; Witter RL; Hunt HD; Reddy SM; Reed WM
    Avian Pathol; 2004 Feb; 33(1):59-68. PubMed ID: 14681069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Open reading frame L1 of Marek's disease herpesvirus is not essential for in vitro and in vivo virus replication and establishment of latency.
    Schat KA; Hooft van Iddekinge BJ; Boerrigter H; O'Connell PH; Koch G
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():841-9. PubMed ID: 9568980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marek's disease: a model for protection against herpesvirus-induced tumours.
    Schat KA
    Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.
    Lesnik F; Ross LJ
    Int J Cancer; 1975 Jul; 16(1):153-63. PubMed ID: 170213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some aspects of lymphomagenesis of Marek's disease of chickens.
    Nazerian K
    Leukemia; 1988 Dec; 2(12 Suppl):198S-203S. PubMed ID: 2848997
    [No Abstract]   [Full Text] [Related]  

  • 30. [Radial immunodiffusion test for the detection of Marek's disease virus in hens].
    Gazdziński P; Cakala A
    Med Weter; 1976 Dec; 32(12):731-4. PubMed ID: 190062
    [No Abstract]   [Full Text] [Related]  

  • 31. [Differentiation of antibodies against turkey herpesvirus and 2 serotypes of Marek's disease virus in the sera of farm chickens].
    Bülow V; Landgraf H; Vielitz E
    Zentralbl Veterinarmed B; 1976 Jun; 23(5-6):391-402. PubMed ID: 183416
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus.
    Calnek BW; Carlisle JC; Fabricant J; Murthy KK; Schat KA
    Am J Vet Res; 1979 Apr; 40(4):541-8. PubMed ID: 229747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marek's disease herpesvirus vaccines integrate into chicken host chromosomes yet lack a virus-host phenotype associated with oncogenic transformation.
    McPherson MC; Cheng HH; Delany ME
    Vaccine; 2016 Nov; 34(46):5554-5561. PubMed ID: 27720297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unique region of Marek's disease virus DNA in a virus-nonproductive lymphoblastoid cell line, MDCC-RP1.
    Nakamura K; Hayashi M; Isogai H; Namioka S
    Nihon Juigaku Zasshi; 1990 Dec; 52(6):1341-5. PubMed ID: 1962835
    [No Abstract]   [Full Text] [Related]  

  • 35. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage.
    Maotani K; Kanamori A; Ikuta K; Ueda S; Kato S; Hirai K
    J Virol; 1986 May; 58(2):657-60. PubMed ID: 3009876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization and phylogenetic analysis of oncogenes from virulent serotype-1 Marek's disease virus in India.
    Prathibha Y; Sreedevi B; Kumar NV; Srilatha CH
    Acta Virol; 2018; 62(3):277-286. PubMed ID: 30160143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Map location of homologous regions between Marek's disease virus and herpesvirus of turkey and the absence of detectable homology in the putative tumor-inducing gene.
    Fukuchi K; Sudo M; Tanaka A; Nonoyama M
    J Virol; 1985 Mar; 53(3):994-7. PubMed ID: 2983105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insertion of reticuloendotheliosis virus long terminal repeat into the genome of CVI988 strain of Marek's disease virus results in enhanced growth and protection.
    Lupiani B; Lee LF; Kreager KS; Witter RL; Reddy SM
    Avian Dis; 2013 Jun; 57(2 Suppl):427-31. PubMed ID: 23901756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of the virus content per vaccination dose on the effectiveness of the immune prevention of Marek's disease in general practice].
    Werner P; Werner O; Schmidt U; Sulk I; Reinhold P; Grünert G; Walter I; Härtling D; Jendreykow M; Exner H
    Arch Exp Veterinarmed; 1985 Sep; 39(5):746-59. PubMed ID: 3000310
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.
    Lee LF; Cui X; Cui Z; Gimeno I; Lupiani B; Reddy SM
    Virus Genes; 2005 Aug; 31(1):73-80. PubMed ID: 15965611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.